Flying L Partners - aVenture Asset Manager Research
Location
Steamboat Springs, CO, US
Founded
2016
Flying L Partners is a venture capital firm specializing in the ophthalmic sector. The firm focuses on identifying and investing in high-potential opportunities within this niche, typically participating in Series A and Series B funding rounds. Their investment strategy involves raising capital specifically for promising ventures and actively engaging with these companies to drive innovation and value creation.
Notable portfolio companies include Aurion Biotech, Surface Pharmaceuticals, Tarsus Pharmaceuticals, and TearClear, which have collectively raised significant capital. The firm's key partners are seasoned professionals with a history of impactful contributions to the ophthalmic industry. Flying L Partners offers unique value-add services by deeply involving themselves in the strategic growth and innovation processes of their portfolio companies.
Flying L Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count4
Top Investment Stages
Series B2 (66.7%)
Series A1 (33.3%)
Stage Mix
Series B 67%Series A 33%
Concentration shown as share of disclosed investments by stage.
